Translating molecular advances in Down syndrome and Fragile X syndrome into therapies by Faundez, V, De Toma, I, Bardoni, B, Bartesaghi, R, Nizetic, D, de la Torre, R, Kadosh, R, Herault, Y, Dierssen, M, Potier, M-C

Circulating 25-hydroxyvitamin D3 in relation to renal cell carcinoma incidence and survival in the EPIC cohort. by Muller, D, Fanidi, A, Midttun, Ø, Steffen, A, Dossus, L, Boutron-Ruault, M, Severi, G, Kühn, T, Katzke, V, de la Torre, R, González, C, Sánchez, M, Dorronsoro, M, Santiuste, C, Barricarte, A, Khaw, K, Wareham, N, Travis, R, Trichopoulou, A, Giotaki, M, Trichopoulos, D, Palli, D, Krogh, V, Tumino, R, Vineis, P